SVB Leerink reiterated coverage on Organogenesis Holdings with a new price target

3/17/21 7:25:46 AM ET

Biotechnology: Pharmaceutical Preparations

Health Care

SVB Leerink reiterated coverage of Organogenesis Holdings with a rating of Outperform and set a new price target of $22.00 from $19.00 previously

Save time and jump to the most important pieces.

Recent Analyst Ratings for
$ORGO

Date	Price Target	Rating	Analyst
6/28/2024	$5.00	Buy	Lake Street
2/7/2024	$5.00	Overweight	Cantor Fitzgerald
6/15/2023	$5.00	Equal-Weight	Morgan Stanley
5/24/2023	$10.00	Neutral → Buy	BTIG Research
11/10/2022		Buy → Neutral	BTIG Research
8/10/2022		Outperform → Perform	Oppenheimer
11/10/2021	$26.00 → $20.00	Outperform	SVB Leerink
8/10/2021	$24.00 → $25.00	Outperform	Credit Suisse